Mesoblast (MEOBF) Deferred Taxes (2016 - 2024)
Mesoblast's (MEOBF) quarterly Deferred Taxes came in at -$191000.0 in Q2 2024, up 9.91% year-over-year from -$173785.4 in Q3 2023, and up 9.91% quarter-over-quarter from -$212000.0 in Q2 2023.
Analysis
Mesoblast (MEOBF) Deferred Taxes (2016 - 2024) Analysis & Trends
Mesoblast has disclosed Deferred Taxes across 9 years of filings, most recently posting -$191000.0 for Q2 2024.
- In Q2 2024, Deferred Taxes rose 9.91% year-over-year to -$191000.0; the TTM figure through Jun 2024 stood at -$520000.0 (down 35.42% YoY), while the FY2026 annual figure was $613000.0, up 85.76% from the prior year.
- Deferred Taxes came in at -$191000.0 for Q2 2024 at Mesoblast, up from -$212000.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $74000.0 in Q4 2020 to a low of -$6.2 million in Q1 2020.
- Average Deferred Taxes over 5 years is -$556214.3, with a median of -$68000.0 recorded in 2021.
- Year-over-year, Deferred Taxes soared 101.76% in 2020 and tumbled 341.67% in 2023.
- Over 5 years, Deferred Taxes stood at $74000.0 in 2020, then sank by 208.11% to -$80000.0 in 2021, then increased by 11.25% to -$71000.0 in 2022, then plunged by 198.59% to -$212000.0 in 2023, then gained by 9.91% to -$191000.0 in 2024.
- Per Business Quant data, the three most recent Deferred Taxes figures were -$191000.0 in Q2 2024, -$212000.0 in Q2 2023, and -$46000.0 in Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | -1.37 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 1.80 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | - |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -191,000.00 |
| Jun 30, 2023 | -212,000.00 |
| Mar 31, 2023 | -46,000.00 |
| Dec 31, 2022 | -71,000.00 |
| Sep 30, 2022 | -55,000.00 |
| Jun 30, 2022 | -48,000.00 |
| Mar 31, 2022 | -45,000.00 |
| Dec 31, 2021 | -80,000.00 |
| Sep 30, 2021 | -62,000.00 |
| Jun 30, 2021 | -65,000.00 |
| Mar 31, 2021 | -98,000.00 |
| Dec 31, 2020 | 74,000.00 |
| Sep 30, 2020 | -730,000.00 |
| Mar 31, 2020 | -6.16 Mn |
| Dec 31, 2019 | -4.20 Mn |
| Sep 30, 2019 | -1.93 Mn |
| Mar 31, 2019 | -2.20 Mn |
| Dec 31, 2018 | -1.64 Mn |
| Sep 30, 2018 | -711,000.00 |
| Jun 30, 2018 | -1.02 Mn |